HER2-Positive Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — HER2-Positive Breast Cancer (Session 1)

published 1 month ago by Dr Neil Love

Proceedings from the first of 2 sessions on HER2-positive breast cancer. Featuring perspectives from Dr Erika Hamilton, including the following topics: Introduction and review of SABCS 2020 Educational Session on HER2-targeted therapy (0:00) Case: A 42-year-old premenopausal woman with ER-positive, HER2-positive, node-negative breast cancer — Laurie Matt-Amaral, MD, MPH (7:59) SABCS 2020 Review (22:55) Case: A 43-year-old woman with ER/PR-negative, HER2-positive breast cancer with brain metastasis — Atif Hussein, MD, MMM (28:00) Case: A 73-year-old woman with clinical T4 ER/PR-negative, HER2-positive breast cancer — Dr Matt-Amaral (43:30) Case: A 36-year-old physician with ER/PR-negative, HER2-positive, node-positive breast cancer during pregnancy — Dr Hussein (51:12) CME information and select publications

more episodes from Research To Practice | Oncology Videos